WebBionomics General Information. Description. Bionomics Ltd is a global, clinical-stage biopharmaceutical company. It is primarily engaged in the development of therapeutics for diseases of the central nervous system and cancer. The company's reportable segment is the Drug Discovery and Development segment which is engaged in the discovery ... WebDec 19, 2024 · Bionomics (ASX:BNO, NASDAQ:BNOX) is a clinical-stage biopharmaceutical company developing novel, allosteric ion channel modulators designed to transform the lives of patients suffering from ...
Investor Relations Bionomics Ltd
WebFeb 24, 2024 · ADELAIDE, Australia, Feb. 23, 2024 (GLOBE NEWSWIRE) -- Bionomics Limited (ASX: BNO, Nasdaq: BNOX), today announced its half-year report for the half-year ended 31 December 2024. The half-year ending 31 December 2024 represented a transformational period for Bionomics in which the Company made great strides on … WebJun 9, 2024 · Background Anopheles stephensi, an invasive malaria vector, was first detected in Africa nearly 10 years ago. After the initial finding in Djibouti, it has subsequently been found in Ethiopia, Sudan and Somalia. To better inform policies and vector control decisions, it is important to understand the distribution, bionomics, insecticide … ron in axie
Investor Relations Bionomics Ltd
WebShe joined Bionomics Limited in 2008 to lead the early clinical development program for BNC210, a small molecule with therapeutic potential for anxiety disorders, and trauma and stressor-related disorders including PTSD. Ms Doolin currently leads Bionomics’ clinical programs across central nervous system disorders and oncology, including ... WebFeb 19, 2024 · Bionomics (BNO), an Australian listed clinical stage biopharmaceutical company announced on Wednesday that it has partnered with EmpathBio, a subsidiary of the largest private psychedelic company, … WebApr 6, 2024 · finance.yahoo.com - April 13 at 10:09 AM. Up almost 1000% in 1 year, the Bionomics (ASX:BNO) share price moves higher. msn.com - March 8 at 1:02 AM. Bionomics' positive pharmacokinetic results confirms it can begin second Phase 2 study to treat PTSD. proactiveinvestors.com.au - February 27 at 2:24 PM. ron i harry potter